StoneX Downgrades Harvard Bioscience to Hold
Harvard Bioscience Inc (HBIO) Q3 2026 Earnings Call Highlights: Revenue Growth Accelerates as ...
Harvard Bioscience, Inc. Q3 2026 Earnings Call Summary
Harvard Bioscience (HBIO) Q3 2026 Earnings Call Transcript
Harvard Bioscience: Q3 Earnings Snapshot
Harvard Bioscience Announces Third Quarter 2026 Financial Results
Harvard Bioscience, Inc. (HBIO) Q3 2026 Earnings Call Transcript
Harvard Bioscience Q3 2026 Earnings Call Transcript
Harvard Bioscience Raises FY2026 Sales Guidance from $88.281M-$90.012M to $89.147M-$90.877M vs $89.794M Est
Harvard Bioscience Sees Q4 Sales $23.700M-$25.500M vs $24.500M Est
Harvard Bioscience to Participate in the Canaccord Genuity MedTech, Diagnostics, and Digital Health and Services Forum
Harvard Bioscience Schedules Third Quarter 2026 Earnings Conference Call for November 10, 2026 at 8:00 AM ET
Harvard Bioscience Announces Creation of Scientific Advisory Board
Harvard Bioscience (HBIO) Q2 2026 Earnings Call Transcript
Benchmark Maintains Speculative Buy on Harvard Bioscience, Raises Price Target to $7.5
Harvard Bioscience, Inc. 2026 Q2 - Results - Earnings Call Presentation
Harvard Bioscience, Inc. Q2 2026 Earnings Call Summary
Harvard Bioscience Inc (HBIO) (Q2 2026) Earnings Call Highlights: Revenue Surges 11% and ...
Harvard Bioscience beats Q2 estimates and raises 2026 revenue guidance
Harvard Bioscience, Inc. (HBIO) Q2 2026 Earnings Call Transcript
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.